A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting

Clinical trial NCT05362903 · COMPLETED

Trial details

NCT number: NCT05362903
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Hypercholesterolemia

Start date: 2022-01-31
Primary completion: 2025-11-28
Enrollment: 1868

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.